IL-4, whose receptor is directly inhibited by dupilumab itself, plays a key role in Th2 differentiation of lymphocytes and IgE production, and it has been shown to be further increased in atopic patients with nasal polyposis compared to non atopic ones [15]. This evidence concerns the gene IL4 and Nasal polyposis.